Akbar Khorasani

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Immune Response

Top Venues

Viral immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Nika Asefi, Parviz Pakzad, Akbar Khorasani, Morteza Taghizadeh, Zahra Amirkhani, Mohammad Hossein Yazdi, Ahmad Reza Shahverdi, Mehdi Mahdavi
Ascorbic Acid and α-Tocopherol in the Inactivated SARS-CoV-2 Vaccine Formulation: Induction of the Th1 Pattern in Aged Mice. Viral immunology (2024)
Somayeh Kalanaky, Saideh Fakharzadeh, Pegah Karimi, Maryam Hafizi, Hamidreza Jamaati, Seyed Mehdi Hassanzadeh, Akbar Khorasani, Mehdi Mahdavi, Mohammad Hassan Nazaran
Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses. Viral immunology (2023)
Melika Haghighi, Akbar Khorasani, Pegah Karimi, Rouhollah Keshavarz, Mehdi Mahdavi
Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses. Viral immunology 35 (10) (2022)
Melika Haghighi, Akbar Khorasani, Pegah Karimi, Rouhollah Keshavarz, Mehdi Mahdavi
Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses. Viral immunology 35 (10) (2022)
Melika Haghighi, Akbar Khorasani, Pegah Karimi, Rouhollah Keshavarz, Mehdi Mahdavi
Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses. Viral immunology 35 (10) (2022)